ZYBERNO
Stock Report
Updated Sep 1, 2026

MANNATECH INC (MTEX)

Healthcare • NASDAQ

$6.95

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
5.0/100
POOR BUSINESS
MANNATECH INC (MTEX) scores 5/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
MARGIN OF SAFETY
Is this stock cheap or expensive relative to what the business has historically generated for owners?
+37.0%
Undervalued
Growth gap unavailable — insufficient data for reverse DCF calculation.
🎯 Expected Annual Return
8.9%
5-year annualised assuming price converges to intrinsic value
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-1.7%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

MANNATECH INC (MTEX) stock report — Zyberno Score 5/100 (POOR BUSINESS), Margin of Safety +37.0%, 9% expected annual return. Full financial analysis on Zyberno.

According to Zyberno's DCF model, MANNATECH INC (MTEX) trades at $6.95 against an estimated intrinsic value per share of $11.04 — a +37.0% Margin of Safety based on Owner Earnings of $2.02M TTM, projected at -2.8% growth for 10 years with a 2.5% terminal growth rate. Zyberno's model translates this into a 5-year expected return of 8.9% annually.

Over the trailing twelve months, MTEX generated $2.02M in Owner Earnings. Capital was deployed as follows: $1.10M paid as dividends. Owner Earnings have declined at 2.8% annually over the trailing five years using log-linear regression.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:6.95
Market Cap:$13.41M

Valuation Multiples (2)

P/S Ratio:0.12x
Peg Ratio:-999.00x

Enterprise Metrics (2)

Enterprise Value:$11.71M
Ev Ebitda Ratio:17.59x

Price Action & Momentum (3)

Momentum Percentile:10 / 100
% of 52-Week High:55.8%
B. Profitability Assessment

Margin Analysis (1)

Ebitda Margin:0.6%

Yield Metrics (3)

Earnings Yield:-$999.00
Owner Earnings Yield:$16.77
Dividend Yield:9.1%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:174.0%
Latest Earnings Filed:2026-05-14

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-7.0%

Earnings Growth (Linear) (1)

Net Income Growth Rate (Linear):-1.8%

Cash Flow Growth (Linear) (2)

Free Cash Flow Growth Rate (Linear):1.6%
Operating Cash Flow Growth Rate (Linear):-2.1%

Operating Growth (Linear) (1)

Operating Income Growth Rate (Linear):-6.8%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:1.15x
Quick Ratio:0.58x
Cash Ratio:0.36x

Leverage Analysis (1)

Debt To Ebitda:6.51x

Coverage Ratios (2)

Interest Coverage Ratio:-1.69x
Times Interest Earned:-1.69

Capital Structure (4)

Working Capital:2,547,000.00
Cash And Cash Equivalents:6,034,000.00
Long Term Debt:$2.75M
Net Debt:-$1.70M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $108.04M
Linear Growth: -7.0%
📊 Click to view full MTEX Revenue analysis & methodology →
Cost Of Revenue Ttm:$27.08M

Profitability Breakdown (2)

Gross profit TTM: $80.96M
Linear Growth: -7.0%
📊 Click to view full MTEX Gross Profit analysis & methodology →
Operating income TTM: -$426.00K
Linear Growth: -6.8%
📊 Click to view full MTEX Operating Income analysis & methodology →

Bottom Line Performance (3)

Net income TTM: -$15.21M
Linear Growth: -1.8%
📊 Click to view full MTEX Net Income analysis & methodology →
Income Before Tax:$3.47M
Ebitda Ttm:666,000.00

Operating Expenses (5)

Operating Expenses:79,362,000.00
R And D Expense:800,000.00
Sga Expense:37,346,000.00
Income Tax Expense:$1.11M
Interest Expense:252,000.00

Expense Ratios (3)

R And D To Revenue Percentage:3.0%
Sga To Revenue Percentage:140.1%
Ebitda Margin:0.6%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$27.47M
Current Assets:$19.41M
Ppe Net:3,232,000.00
Goodwill:0.00
Intangible Assets:$237.00K

Liability Structure (4)

Total Liabilities:32,439,000.00
Current Liabilities:16,865,000.00
Long Term Debt:$2.75M
Short Term Debt:$1.58M

Equity & Capital (3)

Equity:-$4.97M
Retained Earnings:-$12.06M
Common Stock:99,000,000.00

Working Capital Items (3)

Accounts Receivable:137,000.00
Inventory:9,593,000.00
Accounts Payable:3,671,000.00

Special Items (2)

Contract Liabilities:1,761,000.00
Stock Based Compensation:54,000.00
C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: -$2.96M
Linear Growth: -2.1%
Free cash flow TTM: -$4.32M
Linear Growth: 1.6%
📊 Click to view full MTEX Free Cash Flow analysis & methodology →

Investment Activities (1)

Investing Cash Flow:-$129.00K

Financing Activities (3)

Financing Cash Flow:-$126.00K
Dividends Paid Ttm:1,098,000.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (1)

Earnings Per Share Ttm:-$7.88

Revenue & Cash Per Share (2)

Sales Per Share Ttm:55.98
Operating Cash Flow Per Share:-$1.54

Book Value & Capital (2)

Book Value Per Share:-$2.58
Cash Per Share:3.13

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:3.38x
Working Capital Turnover Ttm:42.42x

Receivables Management (2)

Receivables Turnover Ttm:788.60x
Days Sales Outstanding Ttm:0.46

Inventory Management (2)

Inventory Turnover Ttm:2.82x
Days Inventory Outstanding Ttm:129.30

Payables & Cash Cycle (2)

Days Payable Outstanding:49.48
Cash Conversion Cycle:80.29
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:40.00
Quality Score:25.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (3)

Owner earnings TTM: $2.02M
Linear Growth: -2.8%
📊 Click to view full MTEX Owner Earnings analysis & methodology →
Owner Earnings Per Share:$1.05
Owner Earnings Yield:$16.77

Growth Assessment (1)

Owner Earnings Growth Rate:-$2.84

Intrinsic Value Models (1)

Return Scenarios (1)

Investment Assessment (1)

Buffett Assessment:Excellent margin of safety
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (3)

Revenue Growth Rate (Linear):-7.0%
Net Income Growth Rate (Linear):-1.8%
Operating Income Growth Rate (Linear):-6.8%

Cash Flow Growth Rates (2)

Free Cash Flow Growth Rate (Linear):1.6%
Operating Cash Flow Growth Rate (Linear):-2.1%

Other Growth Rates (3)

Gross Profit Growth Rate (Linear):-7.0%
Book Value Growth Rate (Linear):-23.8%
Owner Earnings Growth Rate:-$2.84
C. Company Profile & Context

Corporate Information (6)

Symbol:MTEX
Company Name:MANNATECH INC
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:1.93M
Shares Outstanding Basic:1.93M
Shares Outstanding Diluted:1.93M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 15:29:20 UTC
Data Timestamp:2026-08-21T16:03:06.595824
Scroll to Top